{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T05:05:59Z","timestamp":1776747959911,"version":"3.51.2"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordination of Higher Education Personnel Improvement","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005669","name":"Research Support Foundation of Para\u00edba State","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.clnesp.2024.03.013","type":"journal-article","created":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T21:47:45Z","timestamp":1711316865000},"page":"158-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Metabolomic analysis of retinopathy stages and amputation in type 2 diabetes"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2211-1858","authenticated-orcid":false,"given":"Tain\u00e1 Gomes","family":"Diniz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Severo de Assis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno Rafael Virginio","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5766-8595","authenticated-orcid":false,"given":"Kamila Sabino","family":"Batista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3576-9023","authenticated-orcid":false,"given":"Alexandre S\u00e9rgio","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Wanderley de Queiroga Evangelista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina Gon\u00e7alves","family":"Monteiro Viturino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri Mangueira","family":"do Nascimento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evandro Ferreira","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josean Fechine","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mussara Gomes","family":"Cavalcanti Alves Monteiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla Patricia","family":"Novaes dos Santos Fechine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anauara","family":"Lima e Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5291-5454","authenticated-orcid":false,"given":"Darlene Camati","family":"Persuhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2024.03.013_bib1","series-title":"Global report on diabetes","year":"2018"},{"key":"10.1016\/j.clnesp.2024.03.013_bib2","series-title":"Global report on diabetes","year":"2019"},{"key":"10.1016\/j.clnesp.2024.03.013_bib3","series-title":"Diretriz da Sociedade Brasileira deDiabetes","year":"2020"},{"key":"10.1016\/j.clnesp.2024.03.013_bib4","series-title":"Preferred practice Pattern\u00ae guidelines. Diabetic retinopathy","year":"2017"},{"key":"10.1016\/j.clnesp.2024.03.013_bib5","series-title":"Intravitreal injection of anti-VEGF antibody induces glomerular endothelial cell injury","author":"Touzani","year":"2019"},{"key":"10.1016\/j.clnesp.2024.03.013_bib6","first-page":"199","article-title":"Intravitreal anti-vegf agents and cardiovascular risk","volume":"15","author":"Porta","year":"2020","journal-title":"Emerg Med"},{"issue":"10","key":"10.1016\/j.clnesp.2024.03.013_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241365","article-title":"Metabolomics profiles associated with diabetic retinopathy in type 2 diabetes patients","volume":"15","author":"Yun","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.clnesp.2024.03.013_bib8","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1039\/C6MB00014B","article-title":"Metabolomics in diabetic complications","volume":"12","author":"Filla","year":"2016","journal-title":"Mol Biosyst"},{"key":"10.1016\/j.clnesp.2024.03.013_bib9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1167\/iovs.62.10.4","article-title":"Metabolomics in diabetic retinopathy: a systematic Review","volume":"62","author":"Hou","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.clnesp.2024.03.013_bib10","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","article-title":"Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales","volume":"110","author":"Wilkinson","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clnesp.2024.03.013_bib11","series-title":"Report of a WHO consultation","year":"1995"},{"key":"10.1016\/j.clnesp.2024.03.013_bib12","first-page":"45","article-title":"Validation of the international physical activity questionnaire (IPAQ version 6): pilot study in Brasilian Young adults","volume":"9","author":"Pardini","year":"2001","journal-title":"Ver Bras Ci\u00ean E Mov"},{"issue":"1","key":"10.1016\/j.clnesp.2024.03.013_bib13","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1210\/clinem\/dgad452","article-title":"Metabolites as risk factors for diabetic retinopathy in patients with type 2 diabetes: a 12-year follow-up study","volume":"109","author":"Fernandes Silva","year":"2024","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.clnesp.2024.03.013_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00592-019-01363-0","article-title":"Metabolomic profile of diabetic retinopathy: a GC-TOFMS-based approach using vitreous and aqueous humor","volume":"57","author":"Wang","year":"2020","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.clnesp.2024.03.013_bib15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nm.4057","article-title":"A\u00a0branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistence","volume":"22","author":"Jang","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.clnesp.2024.03.013_bib16","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ajo.2021.09.021","article-title":"Plasma arginine and citrulline are elevated in diabetic retinopathy","volume":"235","author":"Peters","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clnesp.2024.03.013_bib17","doi-asserted-by":"crossref","first-page":"871291","DOI":"10.3389\/fmolb.2022.871291","article-title":"Serum untargeted metabolomics reveal potential biomarkers of progression of diabetic retinopathy in asians","volume":"9","author":"Wang","year":"2022","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.clnesp.2024.03.013_bib18","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1210\/clinem\/dgaa370","article-title":"3-Hydroxybutyrate: minor metabolite - major medical manifestations","volume":"105","author":"Moller","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnesp.2024.03.013_bib19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11306-018-1383-3","article-title":"Plasma glutamine and glutamic acid are potential biomarkers for predicting diabetic retinopathy","volume":"14","author":"Rhee","year":"2018","journal-title":"Metabolomics"},{"key":"10.1016\/j.clnesp.2024.03.013_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12986-019-0358-3","article-title":"Plasma metabolomic profiling of proliferative diabetic retinopathy","volume":"28","author":"Zhu","year":"2019","journal-title":"Nutr Metab (Lond)"},{"key":"10.1016\/j.clnesp.2024.03.013_bib21","first-page":"91","article-title":"Glutamine and type 1 diabetes mellitus","volume":"1","author":"Darmaun","year":"2018","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.clnesp.2024.03.013_bib22","doi-asserted-by":"crossref","first-page":"1037164","DOI":"10.3389\/fendo.2022.1037164","article-title":"Metabolomics of various samples advancing biomarker discovery and pathogenesis elucidation for diabetic retinopathy","volume":"13","author":"Du","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.clnesp.2024.03.013_bib23","first-page":"350","article-title":"Diabetes and branched-chain amino acids: what is the link?","volume":"10","author":"Bloomgarden","year":"2018","journal-title":"J\u00a0Diabetes"},{"key":"10.1016\/j.clnesp.2024.03.013_bib24","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1038\/s41598-022-11970-7","article-title":"Targeted metabolomics analysis of amino acids and acylcarnitines as risk markers for diabetes by LC\u2013MS\/MS technique","volume":"12","author":"Hosseinkhani","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.clnesp.2024.03.013_bib25","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1006\/mgme.1999.2880","article-title":"Expression of the human phenylalanine hydroxylase gene in kidney and other non-hepatic tissues","volume":"316","author":"Lichter","year":"1999","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.clnesp.2024.03.013_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000877","article-title":"Plasma phenylalanine and tyrosine and their interactions with diabetic nephropathy for risk of diabetic retinopathy in type 2 diabetes","volume":"8","author":"Luo","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.clnesp.2024.03.013_bib27","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1038\/s41467-022-32000-0","article-title":"Phenylalanine impairs insulin signaling and inhibits glucose uptake through modification of Ir\u03b2","volume":"13","author":"Zhou","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.clnesp.2024.03.013_bib28","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jpba.2019.06.013","article-title":"Metabolic characterization of diabetic retinopathy: an 1H-NMR-based metabolomic approach using human aqueous humor","volume":"10","author":"Jin","year":"2019","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.clnesp.2024.03.013_bib29","first-page":"1877","article-title":"Serum metabolic signatures of chronic limb-threatening ischemia in patients with peripheral artery disease","volume":"16","author":"Azab","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.clnesp.2024.03.013_bib30","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00125-018-4619-x","article-title":"Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial","volume":"61","author":"Welsh","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnesp.2024.03.013_bib31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/10611860802438736","article-title":"N-Acetylcarnosine and histidyl-hydrazide are potent agents for multitargeted ophthalmic therapy of senile cataracts and diabetic ocular complications","volume":"17","author":"Babizhayev","year":"2009","journal-title":"J\u00a0Drug Target"},{"key":"10.1016\/j.clnesp.2024.03.013_bib32","article-title":"Role of dietary histidine in the prevention of obesity and metabolic syndrome","volume":"1","author":"Nicolantonio","year":"2018","journal-title":"Open Heart"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457724000688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457724000688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T06:23:06Z","timestamp":1721110986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457724000688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":32,"alternative-id":["S2405457724000688"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2024.03.013","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolomic analysis of retinopathy stages and amputation in type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2024.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}